MedTrace Logo

Abuse Liability and Human Pharmacology of Mephedrone

NCT02232789 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-12-04

No results posted yet for this study

Summary

The purposes of this study are 1) to evaluate the abuse liability and human pharmacology of mephedrone after oral administration and 2) to compare the pharmacological effects of mephedrone with those obtained after administration of oral 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Conditions

  • Amphetamine-Related Disorders

Interventions

DRUG

Mephedrone

Single oral dose mephedrone

DRUG

3,4-methylenedioxymethamphetamine

Single oral dose MDMA

DRUG

Placebo

Single oal dose placebo

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Parc de Salut Mar

    lead OTHER

Principal Investigators

  • Magi Farre, MD, PhD · Parc de Salut Mar

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02232789 on ClinicalTrials.gov